实时全球研报
HSBC Holdings plc: Singapore Life sale in line with the Group’s strategic direction
研报英文原文证据摘录
HSBC Holdings plc: Singapore Life sale in line with the Group’s strategic direction
C A Z E N O V E Europe Equity Research
24 July 2026
HSBC Holdings plc Neutral
HSBA.L, HSBA LN
Singapore Life sale in line with the Group’s strategic Price (23 Jul 26):1,527p
direction Price Target (Dec-27):1,380p
HSBC announced the sale of 100% of HSBC Life Singapore to Allianz for US European Banks
AC$2.1bn, implying a valuation of c.1.55x HSBC Life Singapore’s FY25 Kian Abouhossein
comprehensive equity, worth up to 15bps CET1 upon completion in 1H27. The (44-20) 7134-4575
Group will also enter into a 15-year exclusive bancassurance agreement with kian.abouhossein@jpmorgan.com
Allianz post-transaction, allowing HSBC to continue offering insurance products J.P. Morgan Securities plc
to its retail and wealth management clients in Singapore and therefore we see a Sheel Shah, CFA
limited impact to client servicing. This transaction is in line with press reports (44-20) 7134-8455
sheel.shah@jpmorgan.com
earlier in the year (see here) and in line with the Group’s strategy to simplify its J.P. Morgan Securities plc
operations, with 13 exit transactions already announced over the past two years
Venkat Madasu
(including HSBC Life Singapore). HSBC Life Singapore has limited scale with a (44-20) 3493-9041
c6% market share and a market position outside of the top 4 in Singapore (trailing venkat.madasu@jpmorgan.com
Great Eastern, AIA, Prudential and Manulife) despite being the #1 insurer for J.P. Morgan Securities plc
HNW clients, and therefore this exit makes strategic sense, in our view, with capital Katherine Lei
likely to be diverted to other high-returning business areas with stronger market (852) 2800-8552
positions.
本摘录由系统从所标注的 PDF 证据页直接提取并保留英文原文,不做批量翻译;登录后在阅读器切换中文时才按需翻译。
打开研报阅读器